|
ECOG-ACRIN NCORP Research Base
|
5UG1CA189828-04
|
$12,699,758
|
|
WAGNER, LYNNE
|
ECOG-ACRIN MEDICAL RESEARCH FOUNDATION
|
|
Alliance NCORP Research Base
|
5UG1CA189823-04
|
$11,328,914
|
|
BUCKNER, JAN
|
MAYO CLINIC ROCHESTER
|
|
Kaiser Permanente NCI National Community Oncology Research Program NCORP
|
5UG1CA189821-04
|
$4,017,836
|
|
FEHRENBACHER, LOUIS
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$3,493,116
|
$873,279
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Wake Forest NCORP Research Base
|
5UG1CA189824-04
|
$3,481,450
|
|
LESSER, GLENN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Heartland Cancer Research NCORP
|
5UG1CA189830-04
|
$2,948,688
|
|
WADE, JAMES
|
DECATUR MEMORIAL HOSPITAL
|
|
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health Study
|
5UM1CA186107-04
|
$2,864,572
|
|
STAMPFER, MEIR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Mayo Clinic Breast Cancer SPORE
|
5P50CA116201-12
|
$2,438,534
|
|
GOETZ, MATTHEW
|
MAYO CLINIC ROCHESTER
|
|
Cancer Research Consortium of West Michigan (CRCWM)
|
5UG1CA189860-04
|
$2,341,117
|
|
YOST, KATHLEEN
|
SPECTRUM HEALTH HOSPITALS
|
|
DF/HCC Kidney Cancer SPORE
|
5P50CA101942-14
|
$2,300,000
|
$276,000
|
MCDERMOTT, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
SPORE in Multple Myeloma
|
5P50CA100707-15
|
$2,300,000
|
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INST
|
|
SPORE for Translational Approaches to Brain Cancer
|
1P50CA221747-01A1
|
$2,300,000
|
$138,000
|
LESNIAK, MACIEJ
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Specialized Program Of Research Excellence (SPORE) in Leukemia
|
5P50CA171963-05
|
$2,300,000
|
|
LINK, DANIEL
|
WASHINGTON UNIVERSITY
|
|
SPORE in Skin Cancer
|
5P50CA174523-05
|
$2,300,000
|
$92,000
|
HERLYN, MEENHARD
|
WISTAR INSTITUTE
|
|
MD Anderson Gynecologic SPORE for Uterine Cancers
|
5P50CA098258-12
|
$2,299,997
|
|
LU, KAREN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
SPORE in Prostate Cancer
|
5P50CA180995-03
|
$2,293,078
|
|
CATALONA, WILLIAM
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
SPORE: Targeted Therapies for Glioma
|
5P50CA165962-05
|
$2,280,112
|
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Translational Research in Breast Cancer (SPORE)
|
5P50CA186784-05
|
$2,251,410
|
$135,085
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
The CSBC Research Center for Cancer Systems Immunology at MSKCC
|
5U54CA209975-02
|
$2,187,373
|
|
LESLIE, CHRISTINA
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Imaging and Tissue Correlates to Optimize Management of Glioblastoma
|
5P01CA118816-10
|
$2,175,899
|
|
CHANG, SUSAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Brain Tumor Therapeutic Efficacy by Quantitative MR
|
5P01CA085878-14
|
$2,054,733
|
|
ROSS, BRIAN
|
UNIVERSITY OF MICHIGAN
|
|
Center for Cancer Nanotechnology Excellence for Translational Diagnostics (CCNE-TD)
|
5U54CA199075-03
|
$2,049,085
|
|
GAMBHIR, SANJIV
|
STANFORD UNIVERSITY
|
|
Modeling the Role of Lymph Node Metastases in Tumor-Mediated Immunosuppression
|
5U54CA209971-02
|
$2,010,406
|
|
PLEVRITIS, SYLVIA
|
STANFORD UNIVERSITY
|
|
Centers for Cancer Systems Therapeutics (CaST)
|
5U54CA209997-02
|
$1,991,657
|
|
CALIFANO, ANDREA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Genetics and Biology of Pancreatic Ductal Adenocarcinoma
|
5P01CA117969-12
|
$1,986,783
|
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Center on the Physics of Cancer Metabolism
|
5U54CA210184-02
|
$1,985,808
|
|
FISCHBACH, CLAUDIA
|
CORNELL UNIVERSITY
|
|
Systems analysis of phenotypic switch in control of cancer invasion
|
5U54CA209992-02
|
$1,937,101
|
|
LEVCHENKO, ANDRE
|
YALE UNIVERSITY
|
|
Biology and Transplantation of the Hematopoietic Stem Cell
|
5P01CA065493-23
|
$1,914,865
|
|
WAGNER, JOHN
|
UNIVERSITY OF MINNESOTA
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$1,860,145
|
$744,058
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Gene therapy of cancer
|
ZIA BC 010985
|
$1,860,145
|
$744,058
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Center for Immunotherapeutic Transport Oncophysics
|
5U54CA210181-02
|
$1,845,151
|
|
FERRARI, MAURO
|
METHODIST HOSPITAL RESEARCH INSTITUTE
|
|
Retrovirus Models of Cancer
|
5P01CA100730-14
|
$1,799,120
|
|
GREEN, PATRICK
|
OHIO STATE UNIVERSITY
|
|
Moffitt Skin Cancer SPORE
|
5P50CA168536-05
|
$1,789,062
|
|
SONDAK, VERNON
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Comparative Modeling of Lung Cancer Prevention and Control Policies
|
5U01CA199284-03
|
$1,765,010
|
|
MEZA, RAFAEL
|
UNIVERSITY OF MICHIGAN
|
|
Overcoming BRAF-inhibitor Resistance in Melanoma
|
5P01CA168585-05
|
$1,688,850
|
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Studies of Childhood Sarcomas
|
5P01CA165995-05
|
$1,624,423
|
|
HOUGHTON, PETER
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
MSKCC -Cornell Center for Translation of Cancer
|
5U54CA199081-03
|
$1,604,099
|
|
BRADBURY, MICHELLE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
The Biology of Prostate Cancer Skeletal Metastases
|
5P01CA093900-13
|
$1,510,770
|
|
KELLER, EVAN
|
UNIVERSITY OF MICHIGAN
|
|
KSHV Persistence and Pathogenesis
|
5P01CA180779-05
|
$1,472,214
|
|
JUNG, JAE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
T-cell receptor gene therapy for cancer
|
ZIA BC 011479
|
$1,424,997
|
$1,068,748
|
Hinrichs, Christian
|
CCR (NCI)
|
|
Direct and Repeated Clinical Measurement of pO2 for Enhancing Cancer Therapy
|
5P01CA190193-03
|
$1,372,998
|
|
SWARTZ, HAROLD
|
DARTMOUTH COLLEGE
|
|
Endoplasmic Reticulum Chaperones in Cancer Biology and Therapy
|
5P01CA186866-03
|
$1,335,301
|
|
LI, ZIHAI
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Biological mechanisms involved with PDT in the treatment of MPM
|
5P01CA087971-14
|
$1,333,497
|
|
GLATSTEIN, ELI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Molecular Tumorigenesis of Bladder Cancer
|
5P01CA165980-05
|
$1,312,471
|
|
WU, XUE-RU
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
The Partnership for Native American Cancer Prevention (2 of 2)
|
5U54CA143924-09
|
$1,285,833
|
|
BRIEHL, MARGARET
|
UNIVERSITY OF ARIZONA
|
|
Novel Molecular Therapies of Prostate Cancer
|
5P01CA140043-08
|
$1,239,835
|
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Comparative Modeling to Inform Cervical Cancer Control Policies
|
5U01CA199334-03
|
$1,225,410
|
|
KIM, JANE
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors
|
5R01CA188943-03
|
$1,225,214
|
|
HILDEBRANDT, MICHELLE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Controlling Esophageal Cancer: A Collaborative Modeling Approach
|
5U01CA199336-03
|
$1,162,462
|
|
HUR, CHIN
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
DNA Polymerase Fidelity Mechanisms: Theory and Experiment
|
5U19CA177547-05
|
$1,093,488
|
|
GOODMAN, MYRON
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
Total relevant funding to Gene Therapy Clinical Trials for this search: $6,543,370
|